Skip to main content
. 2014 Mar 18;9(3):e91248. doi: 10.1371/journal.pone.0091248

Figure 5. 11β-HSD1 content in visceral fat is attenuated with RU486 treatment but not with C113176 or C108297 treatment.

Figure 5

No changes were found in lipolytic protein levels with treatment of antagonists. 11β-HSD1 content was measured in epididymal fat pads to represent visceral adipose tissue and expressed relative to α-tubulin content (A). CD36 protein levels were measured from epididymal fat pads (B) as well as adipose triglyceride lipase (ATGL) (C) and hormone-sensitive lipase (HSL) (D) protein levels as markers of lipolytic adipose tissue activity and expressed relative to loading control. Bars that do not share similar letters denote statistical significance, p<0.05 one-way ANOVA using Tukey's post-hoc test. n = 5–6. All values are means ± SE.